XML 20 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2018
Dec. 31, 2017
Investments:    
Fixed maturities, available-for-sale, at fair value (amortized cost: December 31, 2018 Successor Company - $14,035; December 31, 2017 Predecessor Company - $20,914) $ 13,839 $ 22,799
Fair Value, Option, Fixed Maturity Securities 12 32
Marketable Securities 116 0
Available-for-sale Securities, Equity Securities 0 154
Mortgage loans (net of valuation allowances: December 31, 2018 Successor Company - $5; December 31, 2017 Predecessor Company - $0) 2,100 2,872
Policy loans, at outstanding balance 1,441 1,432
Alternative Investment 894 1,001
Other investments 201 213
Short-term investments 844 1,094
Total investments 19,447 29,597
Cash 221 537
Premiums receivable and agents’ balances, net 12 15
Reinsurance recoverables 29,564 20,785
Deferred policy acquisition costs and value of business acquired 0 405
Deferred income taxes, net 969 556
Intangible Assets, Net (Excluding Goodwill) 51 0
Other Assets 352 1,003
Separate Account Assets 98,814 115,834
Total assets 150,146 168,732
Liabilities    
Reserve for future policy benefits 18,323 14,482
Other policyholder funds and benefits payable 28,584 29,228
Other Liabilities 2,420 2,508
Separate account liabilities 98,814 115,834
Total liabilities 148,141 162,052
Commitments and Contingencies
Stockholder’s Equity    
Common stock—1,000 shares authorized, issued and outstanding, par value $5,690 6 6
Additional paid-in capital 1,761 3,539
Accumulated other comprehensive (loss) income, net of tax (171) 1,023
Retained earnings 409 2,112
Stockholders' Equity Attributable to Parent 2,005 6,680
Total liabilities and stockholder’s equity $ 150,146 $ 168,732